You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 6, August 13, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Statistics and Research Methods
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Documenting Biospecimen Conditions in Reports of Studies

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study of breast cancer gene expression signatures by Dr Acharya and colleagues1 provides the type of information needed to further the goals of personalized molecular medicine. However, the validation of such findings by other researchers is necessary before this type of information can be clinically useful. One of the major problems in validating such studies is the lack of a detailed description of how the biospecimens, which are the foundation of these molecular studies, were collected, transported, preserved, processed, and stored for the actual testing.2 This information was not provided in the article. An investigation of the references and Gene Expression Omnibus (GEO) records3 for the 5 data sets used in the study indicated that 2 did not supply any information about the tumor tissues from which the RNA was isolated for study, 2 gave basic information that the tissue was frozen, and 1 gave detailed . . . [Full Text of this Article]

James A. Robb, MD; Helen M. Moore, PhD
moorehe@mail.nih.gov

Carolyn C. Compton, MD, PhD
Office of Biorepositories and Biospecimen Research
National Cancer Institute
Bethesda, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer
Chaitanya R. Acharya, David S. Hsu, Carey K. Anders, Ariel Anguiano, Kelly H. Salter, Kelli S. Walters, Richard C. Redman, Sascha A. Tuchman, Cynthia A. Moylan, Sayan Mukherjee, William T. Barry, Holly K. Dressman, Geoffrey S. Ginsburg, Kelly P. Marcom, Katherine S. Garman, Gary H. Lyman, Joseph R. Nevins, and Anil Potti
JAMA. 2008;299(13):1574-1587.
ABSTRACT | FULL TEXT  

RELATED LETTER

Documenting Biospecimen Conditions in Reports of Studies—Reply
Chaitanya R. Acharya and Anil Potti
JAMA. 2008;300(6):651.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.